These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31650223)

  • 1. Cost-effectiveness of precision medicine: a scoping review.
    Kasztura M; Richard A; Bempong NE; Loncar D; Flahault A
    Int J Public Health; 2019 Dec; 64(9):1261-1271. PubMed ID: 31650223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist.
    Doble B; Tan M; Harris A; Lorgelly P
    Expert Rev Mol Diagn; 2015 Feb; 15(2):235-54. PubMed ID: 25142227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making?
    Husereau D; Marshall DA; Levy AR; Peacock S; Hoch JS
    Int J Technol Assess Health Care; 2014 Apr; 30(2):179-87. PubMed ID: 24806420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the value for money of precision medicine: a systematic literature review and meta-analysis.
    Chen W; Wong NCB; Wang Y; Zemlyanska Y; Butani D; Virabhak S; Matchar DB; Prapinvanich T; Teerawattananon Y
    Front Public Health; 2023; 11():1151504. PubMed ID: 38074712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of test accuracy in economic evaluations of companion diagnostics.
    San Miguel L; Hulstaert F
    J Comp Eff Res; 2015 Nov; 4(6):569-77. PubMed ID: 26529499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing.
    Doble B; John T; Thomas D; Fellowes A; Fox S; Lorgelly P
    Lung Cancer; 2017 May; 107():22-35. PubMed ID: 27316470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the underlying causes of undernutrition. Cost-effectiveness of a multifactorial personalized intervention in community-dwelling older adults: A randomized controlled trial.
    van der Pols-Vijlbrief R; Wijnhoven HAH; Bosmans JE; Twisk JWR; Visser M
    Clin Nutr; 2017 Dec; 36(6):1498-1508. PubMed ID: 27836308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis.
    Vellekoop H; Versteegh M; Huygens S; Corro Ramos I; Szilberhorn L; Zelei T; Nagy B; Tsiachristas A; Koleva-Kolarova R; Wordsworth S; Rutten-van Mölken M;
    Value Health; 2022 Aug; 25(8):1428-1438. PubMed ID: 35248467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review.
    Wright SJ; Newman WG; Payne K
    Pharmacoeconomics; 2019 Aug; 37(8):1011-1027. PubMed ID: 31087278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials.
    Nosrati M; Nikfar S; Hasanzad M
    Expert Rev Pharmacoecon Outcomes Res; 2022 Oct; 22(7):1061-1070. PubMed ID: 35912498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine.
    Zaric GS
    Pharmacoeconomics; 2016 Jul; 34(7):635-44. PubMed ID: 26899833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions.
    Pataky RE; Bryan S; Sadatsafavi M; Peacock S; Regier DA
    Pharmacoeconomics; 2022 Oct; 40(10):931-941. PubMed ID: 35895254
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.